Literature DB >> 8058937

Head and neck neoplasms: magnetization transfer analysis.

D M Yousem1, K T Montone, L M Sheppard, V M Rao, G S Weinstein, R E Hayden.   

Abstract

PURPOSE: Magnetization transfer (MT) imaging enables analysis of the contribution of restricted motion protons in the macromolecular pool to magnetic resonance (MR) signal intensity. The authors undertook this study to determine whether MT ratios (MTRs) could be used to predict pathologic characteristics of head and neck neoplasms.
MATERIALS AND METHODS: Fifty-four patients with pathologically proved neoplasms (squamous cell carcinomas, n = 33; non-squamous cell carcinomas, n = 11; benign masses, n = 10) underwent MT imaging. MTRs were correlated with pathologic findings.
RESULTS: No statistically significant correlations were noted between MTRs and degree of differentiation, keratinization, cells per high-power field, and rate of mitosis. Statistically significant differences were found between MTRs of malignancies and muscle (P < .01), cerebrospinal fluid (P < .001), fat (P < .001), and benign neoplasms (P < .001). MTRs of muscle were higher than those of benign, squamous cell, and non-squamous cell neoplasms.
CONCLUSION: MT imaging shows promise in differentiation of benign from malignant head and neck neoplasms. No statistically significant differences in MTRs were noted among malignancies.

Entities:  

Mesh:

Year:  1994        PMID: 8058937     DOI: 10.1148/radiology.192.3.8058937

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  2 in total

1.  Magnetization transfer of pure DNA and purified sperm nuclei.

Authors:  A Virta; M Kormano; J Paranko
Journal:  MAGMA       Date:  1996-06       Impact factor: 2.310

2.  Amide proton transfer imaging of 9L gliosarcoma and human glioblastoma xenografts.

Authors:  Amandeep Salhotra; Bachchu Lal; John Laterra; Phillip Zhe Sun; Peter C M van Zijl; Jinyuan Zhou
Journal:  NMR Biomed       Date:  2008-06       Impact factor: 4.044

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.